SCHEMBL29835241

SCHEMBL29835241

CC(C)C[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ NPY4R P50391 13/20 0.61
▸ NPY1R P25929 8/20 0.61
▸ NPY5R Q15761 7/20 0.61
▸ NPY2R P49146 4/20 0.61
▸ TFPI P10646 1/20 0.57
▸ KISS1R Q969F8 5/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30924757 0.97 NPY4R (0.58) NPY4RNPY1RNPY5RNPY2RTFPI
SCHEMBL29835305 0.96 TFPI (0.61) NPY4RNPY1RNPY5RNPY2RTFPI
SCHEMBL30612278 0.94 NPY4R (0.59) NPY4RNPY1RNPY5RNPY2RKISS1R
SCHEMBL30924753 0.93 NPY4R (0.57) NPY4RNPY1RNPY5RNPY2RTFPI
SCHEMBL30924746 0.92 TFPI (0.59) NPY4RNPY1RNPY5RNPY2RTFPI
SCHEMBL30924750 0.91 TFPI (0.60) NPY4RNPY1RNPY5RNPY2RTFPI
SCHEMBL30924735 0.90 TFPI (0.59) NPY4RNPY1RNPY5RNPY2RTFPI
SCHEMBL29434670 0.89 NPY4R (0.65) NPY4RNPY1RNPY5RNPY2RKISS1R
SCHEMBL31264972 0.89 BACE1 (0.54) TFPIKISS1R
SCHEMBL30257868 0.89 NPY4R (0.63) NPY4RNPY1RNPY5RNPY2RTFPI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4313100-A2 PEPTIDES AND METHODS FOR REDUCING SKIN PIGMENTATION GLO Pharma, Inc. (US) 2024-02-07 — — EP disclosed
WO-2022204305-A2 PEPTIDES AND METHODS FOR REDUCING SKIN PIGMENTATION GLO PHARMA, INC. (US) 2022-09-29 — — WO disclosed
Send feedback